Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1947 1
1948 1
1949 2
1950 2
1951 3
1952 1
1954 2
1955 4
1956 2
1957 4
1958 2
1959 7
1960 4
1961 3
1962 2
1963 4
1964 4
1965 2
1966 7
1967 9
1968 7
1969 7
1970 9
1971 8
1972 8
1973 6
1974 9
1975 2
1976 3
1977 4
1978 5
1979 7
1980 8
1981 5
1982 9
1983 15
1984 8
1985 15
1986 25
1987 29
1988 28
1989 22
1990 25
1991 31
1992 30
1993 24
1994 33
1995 29
1996 43
1997 36
1998 32
1999 23
2000 27
2001 31
2002 30
2003 38
2004 53
2005 60
2006 63
2007 53
2008 69
2009 52
2010 60
2011 54
2012 54
2013 72
2014 70
2015 75
2016 92
2017 89
2018 64
2019 92
2020 86
2021 99
2022 49
Text availability
Article attribute
Article type
Publication date

Search Results

1,854 results
Results by year
Filters applied: . Clear all
Page 1
Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy.
León-Castillo A, de Boer SM, Powell ME, Mileshkin LR, Mackay HJ, Leary A, Nijman HW, Singh N, Pollock PM, Bessette P, Fyles A, Haie-Meder C, Smit VTHBM, Edmondson RJ, Putter H, Kitchener HC, Crosbie EJ, de Bruyn M, Nout RA, Horeweg N, Creutzberg CL, Bosse T; TransPORTEC consortium. León-Castillo A, et al. Among authors: powell me. J Clin Oncol. 2020 Oct 10;38(29):3388-3397. doi: 10.1200/JCO.20.00549. Epub 2020 Aug 4. J Clin Oncol. 2020. PMID: 32749941 Free PMC article.
COVID-19 and Changes in Child Obesity.
Jenssen BP, Kelly MK, Powell M, Bouchelle Z, Mayne SL, Fiks AG. Jenssen BP, et al. Among authors: powell m. Pediatrics. 2021 May;147(5):e2021050123. doi: 10.1542/peds.2021-050123. Epub 2021 Mar 2. Pediatrics. 2021. PMID: 33653879 No abstract available.
Endometrial cancer.
Crosbie EJ, Kitson SJ, McAlpine JN, Mukhopadhyay A, Powell ME, Singh N. Crosbie EJ, et al. Among authors: powell me. Lancet. 2022 Apr 9;399(10333):1412-1428. doi: 10.1016/S0140-6736(22)00323-3. Lancet. 2022. PMID: 35397864 Review.
Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial.
de Boer SM, Powell ME, Mileshkin L, Katsaros D, Bessette P, Haie-Meder C, Ottevanger PB, Ledermann JA, Khaw P, Colombo A, Fyles A, Baron MH, Jürgenliemk-Schulz IM, Kitchener HC, Nijman HW, Wilson G, Brooks S, Carinelli S, Provencher D, Hanzen C, Lutgens LCHW, Smit VTHBM, Singh N, Do V, D'Amico R, Nout RA, Feeney A, Verhoeven-Adema KW, Putter H, Creutzberg CL; PORTEC study group. de Boer SM, et al. Among authors: powell me. Lancet Oncol. 2018 Mar;19(3):295-309. doi: 10.1016/S1470-2045(18)30079-2. Epub 2018 Feb 12. Lancet Oncol. 2018. PMID: 29449189 Free PMC article. Clinical Trial.
ARCTIC: durvalumab with or without tremelimumab as third-line or later treatment of metastatic non-small-cell lung cancer.
Planchard D, Reinmuth N, Orlov S, Fischer JR, Sugawara S, Mandziuk S, Marquez-Medina D, Novello S, Takeda Y, Soo R, Park K, McCleod M, Geater SL, Powell M, May R, Scheuring U, Stockman P, Kowalski D. Planchard D, et al. Among authors: powell m. Ann Oncol. 2020 May;31(5):609-618. doi: 10.1016/j.annonc.2020.02.006. Epub 2020 Feb 20. Ann Oncol. 2020. PMID: 32201234 Free article. Clinical Trial.
1,854 results